Effect of sex hormone level on incidence of postoperative delirium

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300070379

Enrollment

Unknown

Registered

2023-04-11

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Group of elderly female patients with general anesthesia:None

Eligibility

Sex/Gender

Female

Age

65 Years to 87 Years

Inclusion criteria

Inclusion criteria: 1. Elderly female patients (=65 years old); 2. General anesthesia; 3. Elective surgery; 4. ASA: Level 2-3; 5. NAYA: Level 1-2.

Exclusion criteria

Exclusion criteria: 1. Did not receive general anesthesia; 2. She is undergoing gynecological surgery; 3. Emergency or high-risk surgery; 4. History of mental illness or nervous system disease; 5. Conduct hormone or steroid treatment within one month before the study, or take oral contraceptives, antihistamines, ranitidine, etc. one month before the study; 6. Serious organ dysfunction including heart, liver or kidney.

Design outcomes

Primary

Measure	Time frame
postoperative delirium;estrogen;testosterone;Luteinizing hormone;Follicle stimulating hormone;Prolactin;ng/ml;	—

Secondary

Measure	Time frame
Anesthesia duration;Surgical duration;degree of education;age;	—

Countries

China

Contacts

Public ContactShiyu Shu

The Second Affiliated Hospital of Chongqing Medical University

shushiyu@hotmail.com+86 18917785284

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026